HOME > NATION > Article

Text Size

small

medium

large


Japan Gives Emergency Approval to Shionogi COVID-19 Pill

Japan Gives Emergency Approval to Shionogi COVID-19 Pill

   Tokyo, Nov. 22 (Jiji Press)--Japanese health minister Katsunobu Kato on Tuesday gave emergency approval to a COVID-19 pill developed by Shionogi & Co. <4507>.
   The Xocova pill became the third oral COVID-19 treatment available for mildly ill patients in Japan and the first developed domestically.
   Earlier on Tuesday, subcommittees of the Pharmaceutical Affairs and Food Sanitation Council, which advises the health minister, gave their green light at a joint meeting, saying that the pill is presumed to be effective.
   It was the first approval issued under a new system for granting emergency regulatory approval to medical goods to put them into practical use quickly in urgent situations.
   In July, the health ministry delayed a decision on whether to approve Xocova, whose generic name is ensitrelvir fumaric acid, noting that the data it had already received were not enough to judge the drug's possible efficacy.

To read a full story, please click here to find out how to subscribe.

NATION

HEADLINES

POLITICS
LDP Shows Opposition Parties Revisions to Unification Church Victim Relief Bill
ECONOMY
Tokyo Forex (5 P.M.): U.S. Dollar=135.12-14 Yen; Euro=1.0538-0540 Dollars
SPORTS
FIFA World Cup: Viewing Rate for Japan-Spain Match at 28.7% in 2nd Half
OTHER
Susono Mayor Accuses Nursery School Head after Staff Arrests over Kids Abuses

AFP-JIJI PRESS NEWS JOURNAL


Photos